How Should You Prepare For Foreign FDA Inspections During COVID-19?

By Ropack

With so much left to learn about Covid-19 ― including whether we will return to the way things were before or if we should prepare for a future that includes a hybrid of pre- and post-Covid lifestyles ― it is important you understand the expectations of regulators during this unprecedented time and what you can do to facilitate paper-based in lieu of on-site inspections.

A deeper knowledge about both could mean the difference between a successful audit and questions and concerns from regulators that lead to costly delays in your program timeline.

To learn more, please download this free white paper.

Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.